This profile was last updated on .
Is this you? Claim your profile.
Express Scripts Inc
One Express Way
Express Scripts manages more than a billion prescriptions each year for tens of millions of people. On behalf of our clients - employers, health plans, unions and government health programs - we make the use of prescription drugs safer and more affordable...
Find other employees at this company (10,063)
(8 Total References)
"We are in a situation where ...
"We are in a situation where new medications are demanding premium pricing even when the new drug may not perform any better than existing alternatives," says Andy Behm, a vice president with Express Scripts.
AIS's Health Business Daily
- Andrew Behm, Pharm.D., senior director of the office of clinical evaluation and policy at Express Scripts, Inc., told AIS'sDRUG BENEFIT NEWS.
Brand-name drugs that generated $8.8 ...
Brand-name drugs that generated $8.8 billion in 2008 retail and mail-order sales will lose patent protection in 2010, says Andrew Behm, Pharm.D., senior director of Express Scripts, Inc.'s office of clinical evaluation and policy.
The two drugs, which had a combined $1.3 billion in 2008 sales, "are going to be first-in-class generics," Behm
But the original version of Effexor increased blood pressure in many patients, Behm
explains, while Effexor XR does not have that effect.
"It's one example where the extended release had a material, not just a theoretical, advantage," he
adds that Express Scripts
doesn't promote switches in the antidepressant class for patients who are stabilized and having success on one drug.
Editorial Board | Clinical Geriatrics
ANDREW BEHM, PHARMD, CGP Assistant Professor, Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy Minneapolis, MN Senior Director, Office of Clinical Evaluation and Policy Express Scripts
ANDREW BEHM, PHARMD, ...
ANDREW BEHM, PHARMD, CGP
Assistant Professor, Department of Experimental and Clinical Pharmacology
University of Minnesota College of Pharmacy